Company Founder Takes the Helm of etectRx, a Digital Health Company
GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of Eric Buffkin as its next president and CEO. etectRx received FDA clearance for its novel ingestible event marker, the ID-Cap™ System in late 2019, and has been building momentum over the past two years through clinical studies and industry partnerships.
Buffkin is a repeat entrepreneur and executive with more than 25 years of experience with tech and health-tech companies. Eric co-founded the company in 2009 with etectRx’s Senior Scientific Advisor, Neil Euliano. Most recently, Buffkin served as senior vice president of development and technical operations at etectRx.
“Eric holds expert knowledge of etectRx and its technology,” said Jeff Spafford, Chairman of etectRx. “Eric’s technical knowledge and industry expertise will be invaluable as we continue to commercialize the ID-Cap System.”
The ID-Cap System provides unequivocal confirmation of medication ingestion to provide unparalleled insight into medication-taking behavior for commercial and clinical-stage products.
“I am excited by the continued potential for the ID-Cap System and etectRx’s opportunity in the burgeoning digital health ecosystem,” Buffkin said. “As I step into this role, I am thankful to be surrounded by a team of people who are committed to the ID-Cap System’s Use Cases and are working tirelessly to help the technology succeed in the marketplace.”
etectRx is a digital health company. Our FDA-cleared ID-Cap System uniquely addresses the issue with patient adherence to (oral) medication. Our accurate, flexible and elegant digital pill system allows pharmaceutical companies to rethink approaches to medication adherence, innovate with confidence and accelerate patient outcomes. To learn more, visit https://etectrx.com/.
Media Contact for etectRx™
Findsome & Winmore